Product Information

TIZANIDINE HCL 4 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1045 per EA under NDC 62332049241. Its NADAC has been published 309 times since Dec 23, 2020.

FDA first approved this application on Jan 13, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TIZANIDINE HCL 4 MG CAPSULE

Tizanidine Hydrochloride
$0.1045per EA

Strength

4 mg/1

NDC

62332049241

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TIZANIDINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213223

FDA Approved

1/13/2020

TE Code

AB

On Market Since

1/15/2020

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for TIZANIDINE HCL 4 MG CAPSULE has been published 309 times since Dec 23, 2020, and over the history we have for it it has declined 60.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per EA
All-time high$0.2858 (Jul 14, 2021)
All-time low$0.0827 (May 22, 2024)
52-week high$0.1045
52-week low$0.0846
Median price$0.1283
Average price$0.1390
Largest weekly change+94.5% (Jun 23, 2021)
Weeks tracked309
Tracking sinceDec 23, 2020

Price History

1W

+3.1%

1M

+8.0%

3M

+18.0%

6M

+13.8%

1Y

-10.3%

3Y

-18.6%

5Y

-43.8%

All

-60.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIZANIDINE HCL 4 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 4 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1045 per EA (NDC 62332049241), effective Nov 18, 2026.

How has the price of TIZANIDINE HCL 4 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has declined 60.8%. It has been tracked across 309 weekly CMS publications since Dec 23, 2020.

What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 4 MG CAPSULE?

Since Dec 23, 2020, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has ranged from a low of $0.0827 (May 22, 2024) to a high of $0.2858 (Jul 14, 2021), with a median of $0.1283 per EA.

Are there cheaper alternatives to TIZANIDINE HCL 4 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TIZANIDINE HCL 4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TIZANIDINE HCL 4 MG CAPSULE?

TIZANIDINE HCL 4 MG CAPSULE (NDC 62332049241) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.